Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Diadexus, Inc.
| Metric | Diadexus, Inc. Healthcare |
|---|---|
| Quality Score | 32 / 100 |
| Revenue (latest) | $6M |
| Net income (latest) | −$970,000 |
| Operating margin | −9.2% |
| Net margin | −17.6% |
| Return on equity | 20.6% |
| Return on assets | −7.4% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | 1.7% |
| Altman Z″ (distress) | -56.88 |
| Accruals / assets | 34.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.